These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 8625071

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ, Yang HX.
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [Abstract] [Full Text] [Related]

  • 43. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ.
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer.
    Top B, Mooi WJ, Klaver SG, Boerrigter L, Wisman P, Elbers HR, Visser S, Rodenhuis S.
    Int J Cancer; 1995 Apr 21; 64(2):83-91. PubMed ID: 7615358
    [Abstract] [Full Text] [Related]

  • 46. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N.
    Hepatogastroenterology; 1999 Apr 21; 46(28):2648-53. PubMed ID: 10522058
    [Abstract] [Full Text] [Related]

  • 47. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, Tan L, Agasthian T, Koong HN, Tam J, Tan C, Caleb M, Chang A, Ng A, Tan P.
    J Thorac Oncol; 2009 Jan 21; 4(1):12-21. PubMed ID: 19096301
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.
    Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas.
    Ab' Saber AM, Massoni Neto LM, Bianchi CP, Ctenas BB, Parra ER, Eher EM, Pereira JC, Takagaki T, Yamaguchi NH, Capelozzi VL.
    Ann Thorac Surg; 2004 Jun 15; 77(6):1883-90. PubMed ID: 15172229
    [Abstract] [Full Text] [Related]

  • 52. BAX and p16INK4A are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer.
    Gessner C, Liebers U, Kuhn H, Stiehl P, Witt C, Schauer J, Wolff G.
    Eur Respir J; 2002 Jan 15; 19(1):134-40. PubMed ID: 11843312
    [Abstract] [Full Text] [Related]

  • 53. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma.
    Mori S, Ito G, Usami N, Yoshioka H, Ueda Y, Kodama Y, Takahashi M, Fong KM, Shimokata K, Sekido Y.
    Cancer; 2004 Apr 15; 100(8):1673-82. PubMed ID: 15073856
    [Abstract] [Full Text] [Related]

  • 54. [Expression profile and prognostic significance of CD24, p53 and p21 in lymphomas. A tissue microarray study of over 600 non-Hodgkin lymphomas].
    Went P, Dellas T, Bourgau C, Maurer R, Augustin F, Tzankov A, Dirnhofer S.
    Dtsch Med Wochenschr; 2004 Oct 01; 129(40):2094-9. PubMed ID: 15455300
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
    Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP.
    J Clin Oncol; 2004 Mar 15; 22(6):1014-24. PubMed ID: 14981102
    [Abstract] [Full Text] [Related]

  • 57. Analysis of cell cycle regulator proteins in non-small cell lung cancer.
    Esposito V, Baldi A, Tonini G, Vincenzi B, Santini M, Ambrogi V, Mineo TC, Persichetti P, Liuzzi G, Montesarchio V, Wolner E, Baldi F, Groeger AM.
    J Clin Pathol; 2004 Jan 15; 57(1):58-63. PubMed ID: 14693837
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.